HAART efficacy for HIV-infected patients increased over time as more drugs and novel drug classes became available. It is not yet fully clear, however, which factors are most relevant to the increased success of more recent first-line regimens. We therefore planned to retrospectively investigate the efficacy of first-line regimens prescribed at our Institutions in 1998 and 2006.
Comparison of the efficacy at 48 weeks of first-line antiretroviral treatment for HIV infection in 1998 and 2006: a multicentric investigation / Madeddu, Giordano; Sozio, Federica; D'Alessandro, Margherita; Polilli, E.; Bonfanti, Paolo; Mazzotta, Elena; Vecchiet, Jacopo; Quirino, Tiziana; Manzoli, Lamberto; Soddu, V.; De Socio, Giuseppe Vittorio Luigi; Mura, Maria Stella Anna; Parruti, Giustino. - In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. - ISSN 1758-2652. - 11:Suppl. 1(2008), p. 19. (Intervento presentato al convegno Abstracts of the 9. International Congress on Drug Therapy in HIV Infection) [10.1186/1758-2652-11-S1-P19].
Comparison of the efficacy at 48 weeks of first-line antiretroviral treatment for HIV infection in 1998 and 2006: a multicentric investigation
Madeddu, Giordano;Mura, Maria Stella Anna;
2008-01-01
Abstract
HAART efficacy for HIV-infected patients increased over time as more drugs and novel drug classes became available. It is not yet fully clear, however, which factors are most relevant to the increased success of more recent first-line regimens. We therefore planned to retrospectively investigate the efficacy of first-line regimens prescribed at our Institutions in 1998 and 2006.| File | Dimensione | Formato | |
|---|---|---|---|
|
Sozio_F_Articolo_2008_Comparison.pdf
accesso aperto
Tipologia:
Versione editoriale (versione finale pubblicata)
Licenza:
Non specificato
Dimensione
132.29 kB
Formato
Adobe PDF
|
132.29 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
